NDC 0069-1540

Norvasc

Amlodipine Besylate

Norvasc is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Amlodipine Besylate.

Product ID0069-1540_3f5ca9a3-9076-49ab-b247-669c337f3364
NDC0069-1540
Product TypeHuman Prescription Drug
Proprietary NameNorvasc
Generic NameAmlodipine Besylate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1992-07-31
Marketing CategoryNDA / NDA
Application NumberNDA019787
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameAMLODIPINE BESYLATE
Active Ingredient Strength10 mg/1
Pharm ClassesCalcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0069-1540-41

100 BLISTER PACK in 1 BOX, UNIT-DOSE (0069-1540-41) > 1 TABLET in 1 BLISTER PACK
Marketing Start Date1992-07-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0069-1540-68 [00069154068]

Norvasc TABLET
Marketing CategoryNDA
Application NumberNDA019787
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1992-07-31

NDC 0069-1540-41 [00069154041]

Norvasc TABLET
Marketing CategoryNDA
Application NumberNDA019787
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1992-07-31

Drug Details

Active Ingredients

IngredientStrength
AMLODIPINE BESYLATE10 mg/1

OpenFDA Data

SPL SET ID:abd6a2ca-40c2-485c-bc53-db1c652505ed
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308136
  • 308135
  • 212549
  • 212542
  • 212575
  • 197361
  • UPC Code
  • 0300691540688
  • 0300691520680
  • Pharmacological Class

    • Calcium Channel Antagonists [MoA]
    • Dihydropyridine Calcium Channel Blocker [EPC]
    • Dihydropyridines [CS]
    • Calcium Channel Antagonists [MoA]
    • Dihydropyridine Calcium Channel Blocker [EPC]
    • Dihydropyridines [CS]

    NDC Crossover Matching brand name "Norvasc" or generic name "Amlodipine Besylate"

    NDCBrand NameGeneric Name
    0069-1520Norvascamlodipine besylate
    0069-1530Norvascamlodipine besylate
    0069-1540Norvascamlodipine besylate
    21695-151NorvascNorvasc
    55289-103NorvascNorvasc
    0054-0100Amlodipine BesylateAmlodipine Besylate
    0054-0101Amlodipine BesylateAmlodipine Besylate
    0054-0102Amlodipine BesylateAmlodipine Besylate
    0093-0083Amlodipine BesylateAmlodipine Besylate
    0093-7167Amlodipine BesylateAmlodipine Besylate
    0093-7168Amlodipine BesylateAmlodipine Besylate
    0143-9959Amlodipine besylateAmlodipine besylate
    0143-9960Amlodipine besylateAmlodipine besylate
    0143-9961Amlodipine besylateAmlodipine besylate
    0179-0210Amlodipine BesylateAmlodipine Besylate
    0179-0211Amlodipine BesylateAmlodipine Besylate
    0179-0213Amlodipine BesylateAmlodipine Besylate
    0378-5208Amlodipine Besylateamlodipine besylate
    0378-5209Amlodipine Besylateamlodipine besylate
    0378-5210Amlodipine Besylateamlodipine besylate
    0480-0083Amlodipine BesylateAmlodipine Besylate
    0480-7167Amlodipine BesylateAmlodipine Besylate
    0480-7168Amlodipine BesylateAmlodipine Besylate
    0603-2108Amlodipine Besylateamlodipine besylate
    0603-2109Amlodipine Besylateamlodipine besylate
    0603-2110Amlodipine Besylateamlodipine besylate
    0615-6577Amlodipine Besylateamlodipine besylate
    0615-6578Amlodipine Besylateamlodipine besylate
    0615-7939Amlodipine BesylateAmlodipine Besylate
    0615-7941AMLODIPINE BESYLATEAMLODIPINE BESYLATE
    0615-7942Amlodipine BesylateAmlodipine Besylate
    0615-8199Amlodipine BesylateAmlodipine Besylate
    0615-8200Amlodipine BesylateAmlodipine Besylate
    0615-8201Amlodipine BesylateAmlodipine Besylate
    0615-8282AMLODIPINE BESYLATEAMLODIPINE BESYLATE

    Trademark Results [Norvasc]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NORVASC
    NORVASC
    73659611 1468768 Live/Registered
    PFIZER INC.
    1987-05-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.